[
  {
    "id": "fc_pulm_rehab_5c442dbb",
    "front": "Prone position: key physiological benefit?",
    "back": "More homogeneous TPP distribution, improved V/Q matching.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_0e7c6182",
    "front": "Prone position reduces which VILI types?",
    "back": "Volutrauma, atelectrauma.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_83ae90a8",
    "front": "PROSEVA trial: prone positioning effect?",
    "back": "Reduced 28-day mortality in severe ARDS.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_83404bdc",
    "front": "PROSEVA: minimum prone session duration?",
    "back": "At least 16 consecutive hours per day.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_79bd3d39",
    "front": "Supine position: ventral vs. dorsal TPP?",
    "back": "Ventral TPP high, dorsal TPP low.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_8532f1c5",
    "front": "Prone: TPP distribution?",
    "back": "More homogeneous transpulmonary pressure distribution.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_46495cda",
    "front": "Prone: Key physiological benefit?",
    "back": "Improves V/Q matching; reduces ventilation inhomogeneity.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_8b3a0a5b",
    "front": "Prone: Effect on VILI, recruitment?",
    "back": "Reduces volutrauma, atelectrauma; increases alveolar recruitment.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_8ee2f101",
    "front": "PROSEVA: Prone's effect on ARDS mortality?",
    "back": "Reduced 28-day mortality (16% vs 32.8% in severe ARDS).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_2f542015",
    "front": "PROSEVA: Recommended proning duration, criteria?",
    "back": "â‰¥16 consecutive hours; PaO2:FiO2 <150mmHg.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_034f372f",
    "front": "ARDS proning: key physiological effects?",
    "back": "Homogenizes TPP, improves V/Q, increases recruitment.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  },
  {
    "id": "fc_pulm_rehab_0e5b5994",
    "front": "PROSEVA trial: ARDS proning outcome?",
    "back": "Early, long proning (12-16h) reduced 28-day mortality.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Pulmonary Rehabilitation",
    "bookId": "pulm_rehab",
    "sourceSection": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
    "sourceLocation": {
      "bookName": "55.SARCOIDOSIS (1)",
      "chapter": "Pulmonary Sarcoidosis Treatment Algorithm",
      "section": "TABLE 2 Immunosuppressive therapies for sarcoidosis",
      "pageNumber": 35
    }
  }
]